Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Artificial Intelligence-based Personalized Rituximab Treatment Protocol in Membranous Nephropathy

NCT06341205 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT06341205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06341205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Artificial Intelligence-based Personalized Rituximab Treatment Protocol in Membranous Nephropathy
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Phase 3
Overall status
Recruiting
Start date
February 4, 2025
Completion date
September 30, 2031
Enrollment
120 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

membranous nephropathy